Infection Risk among HS Patients Compared to Psoriasis: JAMA
Adults with moderate to severe hidradenitis suppurativa (HS) treated with adalimumab face a significantly higher risk of serious infections compared to those with psoriasis, according to a new cohort study published in JAMA Dermatology. Researchers analyzed U.S. insurance claims data of 10,349 adults initiating adalimumab between 2017–2020—1,650 with HS and 8,699 with psoriasis. They found […]